t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Blood. 2008 Jan 1;111(1):387-91. doi: 10.1182/blood-2007-07-092015. Epub 2007 Oct 16.

Abstract

Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report the translocation, t(6;14)(p22;q32), involving IGH@ as a novel recurrent translocation in 13 BCP-ALL patients. Fluorescence in situ hybridization and long-distance inverse polymerase chain reaction (PCR) identified ID4 as the partner gene. Breakpoints were scattered over a 19kb region centromeric of ID4. Quantitative real-time PCR showed up-regulation of ID4 mRNA. All patients had deletions of CDKN2A and PAX5 located on the short arm of chromosome 9, frequently as a result of an isochromosome, i(9)(q10) (9/13, 69%). This study defines a new subgroup of BCP-ALL characterized by ID4 over-expression and CDKN2A and PAX5 deletions. Preliminary survival data suggest that this subgroup may be associated with a good response to therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Base Sequence
  • Child
  • Chromosomes, Human, Pair 14
  • Chromosomes, Human, Pair 6
  • Chromosomes, Human, Pair 9
  • Female
  • Gene Deletion
  • Genes, p16
  • Humans
  • Immunoglobulin Heavy Chains / genetics*
  • In Situ Hybridization, Fluorescence
  • Inhibitor of Differentiation Proteins / genetics*
  • Leukemia, B-Cell / genetics*
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • PAX5 Transcription Factor / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Translocation, Genetic*

Substances

  • ID4 protein, human
  • Immunoglobulin Heavy Chains
  • Inhibitor of Differentiation Proteins
  • PAX5 Transcription Factor
  • PAX5 protein, human